Grey Matters Health Opens First U.S. Brain-Dedicated PET Neuroimaging Clinic

  • Grey Matters Health to open its first NovaScan Neuroimaging Clinic in Davie, Florida by September 30, 2026.
  • Clinic will use FDA-cleared CareMiBrain™ system for brain PET scans, reducing radiation exposure by 25%.
  • Scans covered by Medicare, Medicaid, and private insurance for patients 65+ with neurodegenerative diseases.
  • Grey Matters plans to expand the clinic network nationally.

Grey Matters Health is entering a rapidly growing market for Alzheimer’s diagnostics, driven by FDA-approved treatments that require beta-amyloid detection. The current supply of PET scanners in the U.S. is insufficient to meet demand, creating an opportunity for specialized clinics like NovaScan Neuroimaging Clinics™. The company's focus on reducing radiation exposure and streamlining patient care could position it as a key player in neurodegenerative disease management.

Market Expansion
Whether Grey Matters can successfully scale its clinic network across the U.S. to meet growing demand for Alzheimer’s diagnostics.
Regulatory Compliance
How the FDA-cleared CareMiBrain™ system will perform in real-world settings and maintain compliance with evolving regulations.
Competitive Dynamics
The pace at which competitors like Eisai, Biogen, and Eli Lilly respond to Grey Matters' entry into the brain PET scan market.